SLC6A3 and Parkinson disease: The connection between decreased levels of BDNF and PD development has been further outlined in vivo by a (123) I-PE2I single-photon emission computer tomography study showing a positive correlation between serum BDNF levels and striatal DAT availability in patients with PD (Ziebell et al., 2012).